Maha Hasaballah1, Raafat Abdel-Malek2, Zeinab Zakaria1, Mohamad Saeed Marie1, Mohammed Sherif Naguib3. 1. Endemic Medicine and Hepato-gastroenterology, Faculty of Medicine, Cairo University, Cairo, Egypt. 2. Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt. 3. Gastrointestinal Endoscopy and Liver Unit, Cairo University, Cairo, Egypt.
Abstract
BACKGROUND: Gastrointestinal (GI) lymphoma is a challenging disease. We aimed to study and characterize the different endoscopic and transabdominal ultrasonography (TUS) features of gut lymphoma and to assess whether TUS has a complementary role to endoscopy in the diagnosis of GI lymphoma. METHODS: This study was conducted on 21 patients with GI lymphoma, attending the GI endoscopy and liver unit, Endemic Medicine Department and Oncology Department in Kasr El Aini Hospital, Cairo University. Patients were subjected to GI endoscopy (upper endoscopy & colonoscopy) and transabdominal ultrasonography. The diagnosis was finally based on histopathology of core biopsies (obtained either endoscopically or by ultrasonography) and immuno-histochemistry. RESULTS: In all 21 patients with GI lymphoma included in this study, TUS could accurately determine the site of disease affection compared to endoscopy which is considered the gold standard for site localization. The main TUS pathologic features detected were increased wall thickness of the affected bowel segment with a mean value of (15.6±5.9 mm) and loss of layering pattern in 16 patients (76%). While the most common endoscopic features were ulcers and mass lesions accounting for 38% of the patients for each. Diffuse large B-cell lymphoma was found in 19 patients (90%). Because of endoscopic biopsies were conclusive in 14 patients (67%), TUS guided biopsy was resorted to in 7 patients and was diagnostic in all of them. CONCLUSIONS: Transabdominal ultrasonography is a useful tool in the diagnosis of GI lymphoma that is complementary to conventional diagnostic endoscopic procedures.
BACKGROUND: Gastrointestinal (GI) lymphoma is a challenging disease. We aimed to study and characterize the different endoscopic and transabdominal ultrasonography (TUS) features of gut lymphoma and to assess whether TUS has a complementary role to endoscopy in the diagnosis of GI lymphoma. METHODS: This study was conducted on 21 patients with GI lymphoma, attending the GI endoscopy and liver unit, Endemic Medicine Department and Oncology Department in Kasr El Aini Hospital, Cairo University. Patients were subjected to GI endoscopy (upper endoscopy & colonoscopy) and transabdominal ultrasonography. The diagnosis was finally based on histopathology of core biopsies (obtained either endoscopically or by ultrasonography) and immuno-histochemistry. RESULTS: In all 21 patients with GI lymphoma included in this study, TUS could accurately determine the site of disease affection compared to endoscopy which is considered the gold standard for site localization. The main TUS pathologic features detected were increased wall thickness of the affected bowel segment with a mean value of (15.6±5.9 mm) and loss of layering pattern in 16 patients (76%). While the most common endoscopic features were ulcers and mass lesions accounting for 38% of the patients for each. Diffuse large B-cell lymphoma was found in 19 patients (90%). Because of endoscopic biopsies were conclusive in 14 patients (67%), TUS guided biopsy was resorted to in 7 patients and was diagnostic in all of them. CONCLUSIONS: Transabdominal ultrasonography is a useful tool in the diagnosis of GI lymphoma that is complementary to conventional diagnostic endoscopic procedures.
Entities:
Keywords:
GI endoscopy; Transabdominal ultrasonography (TUS); diffuse large B-cell lymphoma (DLBCL); gastrointestinal lymphoma (GI lymphoma)
Authors: S F Marco-Doménech; S Gil-Sánchez; P Fernández-García; P De La Iglesia-Carreña; M Gonzalez-Añón; J J Arenas-Jimenez; S Alonso-Charterina; R M Piqueras-Olmeda Journal: AJR Am J Roentgenol Date: 2001-01 Impact factor: 3.959
Authors: Asma Ouakaa-Kchaou; Dalenda Gargouri; Asma Kochlef; H Elloumi; H Bouzid; A Kilani; M Romani; J Kharrat; Abdeljabbar Ghorbel Journal: Tunis Med Date: 2011 Aug-Sep
Authors: P Koch; F del Valle; W E Berdel; N A Willich; B Reers; W Hiddemann; B Grothaus-Pinke; G Reinartz; J Brockmann; A Temmesfeld; R Schmitz; C Rübe; A Probst; G Jaenke; H Bodenstein; A Junker; C Pott; J Schultze; A Heinecke; R Parwaresch; M Tiemann Journal: J Clin Oncol Date: 2001-09-15 Impact factor: 44.544
Authors: A Landolsi; I Chabchoub; S Limem; O Gharbi; R Chaafai; M Hochlef; L B Fatma; M Trimech; A Krifa; S Ajmi; M Mokni; M B Hadj Hmida; S B Ahmed Journal: Bull Cancer Date: 2010-04 Impact factor: 1.276
Authors: Lindsay M Morton; Patricia Hartge; Theodore R Holford; Elizabeth A Holly; Brian C H Chiu; Paolo Vineis; Emanuele Stagnaro; Eleanor V Willett; Silvia Franceschi; Carlo La Vecchia; Ann Maree Hughes; Wendy Cozen; Scott Davis; Richard K Severson; Leslie Bernstein; Susan T Mayne; Fred R Dee; James R Cerhan; Tongzhang Zheng Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-04 Impact factor: 4.254
Authors: Christopher N Andrews; M John Gill; Stefan J Urbanski; Douglas Stewart; Rafael Perini; Paul Beck Journal: Am J Gastroenterol Date: 2008-06-28 Impact factor: 10.864